JP Stock MarketDetailed Quotes

4553 TOWA Pharmaceutical

Watchlist
  • 3085
  • -65-2.06%
20min DelayMarket Closed Nov 1 15:00 JST
158.93BMarket Cap9.39P/E (Static)

TOWA Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

TOWA Pharmaceutical Q2 2025 Estimates Date

Currency：JPYNov 12, 2024

Estimate YoY
Revenue
59.73B
+13.03%
EPS
49.62
+10.87%
Analyst Rating
Strong Buy

Sep 4, 2024

TOWA Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q3-- / 68.783B--
Nov 12, 20242025/Q2-- / 59.733B--
Aug 8, 20242025/Q162.566B / 61.500B--
May 14, 20242024/Q459.609B / 61.606B--
Feb 13, 20242024/Q360.929B / 55.735B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q3-- / 68.783B--
Nov 12, 20242025/Q2-- / 59.733B--
Aug 8, 20242025/Q162.566B / 61.500B--
May 14, 20242024/Q459.609B / 61.606B--
Feb 13, 20242024/Q360.929B / 55.735B--

Unlock Free Earnings Estimates

TOWA Pharmaceutical Earnings Reports

  • TOWA Pharmaceutical: Announcement of revised financial estimates.

    Aug 8 02:00 ET

  • TOWA Pharmaceutical: Supplementary explanation materials for Q1 financial results in March 2025.

    Aug 8 02:00 ET

  • TOWA Pharmaceutical: Short-term financial statements for the first quarter of March 2025 [Japanese standards] (consolidated)

    Aug 8 02:00 ET

  • TOWA Pharmaceutical: Confirmatory letter.

    Jul 10 03:04 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Sep 4, 2024

    Strong Buy

    • Strong Buy

      75.00%

    • Buy

      0.00%

    • Hold

      25.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    JP
    Overall
    Symbol
    Latest Price
    % Chg

    No Data